SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-072687
Filing Date
2022-03-11
Accepted
2022-03-11 07:59:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d299646d424b5.htm 424B5 540907
2 GRAPHIC g299646g51z48.jpg GRAPHIC 52601
3 GRAPHIC g299646g54q90.jpg GRAPHIC 20925
  Complete submission text file 0001193125-22-072687.txt   643684
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-259444 | Film No.: 22731178
SIC: 2836 Biological Products, (No Diagnostic Substances)